Cytoreductive surgery after recurrent epithelial ovarian cancer and at other timepoints

doi:10.5317/wjog.v2.i4.101

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8356)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

558

HTML

3748

Figures (1-1)

1182

Tables (1-1)

473

Sum=5961

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1047

Download

1349

Sum=2396

Nov 10, 2013 (publication date) through Dec 11, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Obstetrics and Gynecology

ISSN

2218-6220

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Topic Highlight

World J Obstet Gynecol. Nov 10, 2013; 2(4): 101-107
Published online Nov 10, 2013. doi: 10.5317/wjog.v2.i4.101

Table 1 Risk model for secondary cytoreductive surgery in patients with recurrent ovarian cancer based on the international collaborative cohort

Impact factors	Scoring
	0	0.8	1.5	1.8	2.4	3
FIGO stage	I/II	III/IV
Residual disease at 1^st surgery	0		> 0
Progression-free interval (mo)	> 16				< 16
ECOG performance status	0-1				2-3
Ca 125 at recurrence (U/mL)	< 105			> 105
Ascites at recurrence	Absent					Present

Low risk ≤ 4.7, complete resection feasible from 53% to 83%; high risk ≥ 4.7, complete resection feasible from 20% to 42%. FIGO: International Federation of Gynecology and Obstetrics; ECOG: Eastern Cooperative Oncology Group.

Full Size Table

Citation: Sammartino P, Cornali T, Malatesta MFD, Piso P. Cytoreductive surgery after recurrent epithelial ovarian cancer and at other timepoints. World J Obstet Gynecol 2013; 2(4): 101-107
URL: https://www.wjgnet.com/2218-6220/full/v2/i4/101.htm
DOI: https://dx.doi.org/10.5317/wjog.v2.i4.101